当前位置：
X-MOL 学术
›
Am. J. Respir. Crit. Care Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Elexacaftor/Tezacaftor/Ivacaftor Markedly Reduces Aspergillus fumigatus in Cystic Fibrosis.
American Journal of Respiratory and Critical Care Medicine ( IF 19.3 ) Pub Date : 2024-11-01 , DOI: 10.1164/rccm.202406-1128rl Sarah J Morgan 1 , David P Nichols 2, 3 , Wendy Ni 1 , Gina Hong 4 , Stephen J Salipante 5 , George M Solomon 6 , Steven M Rowe 7 , John P Clancy 8, 9 , Robert A Cramer 10 , Pradeep K Singh 11 ,
中文翻译：
Elexacaftor/Tezacaftor/Ivacaftor 显着减少囊性纤维化中的烟曲霉。
更新日期：2024-08-27
American Journal of Respiratory and Critical Care Medicine ( IF 19.3 ) Pub Date : 2024-11-01 , DOI: 10.1164/rccm.202406-1128rl Sarah J Morgan 1 , David P Nichols 2, 3 , Wendy Ni 1 , Gina Hong 4 , Stephen J Salipante 5 , George M Solomon 6 , Steven M Rowe 7 , John P Clancy 8, 9 , Robert A Cramer 10 , Pradeep K Singh 11 ,
Affiliation
中文翻译：
Elexacaftor/Tezacaftor/Ivacaftor 显着减少囊性纤维化中的烟曲霉。
京公网安备 11010802027423号